1. Home
  2. CCCC vs NPWR Comparison

CCCC vs NPWR Comparison

Compare CCCC & NPWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo C4 Therapeutics Inc.

CCCC

C4 Therapeutics Inc.

N/A

Current Price

$2.75

Market Cap

185.1M

Sector

Health Care

ML Signal

N/A

Logo NET Power Inc.

NPWR

NET Power Inc.

N/A

Current Price

$1.87

Market Cap

193.9M

Sector

Energy

ML Signal

N/A

Company Overview

Basic Information
Metric
CCCC
NPWR
Founded
2015
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
185.1M
193.9M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
CCCC
NPWR
Price
$2.75
$1.87
Analyst Decision
Strong Buy
Buy
Analyst Count
6
2
Target Price
$12.20
$3.50
AVG Volume (30 Days)
2.7M
813.9K
Earning Date
05-25-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
16.45
N/A
EPS
N/A
N/A
Revenue
$35,947,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
1.02
N/A
52 Week Low
$1.09
$1.48
52 Week High
$3.82
$5.20

Technical Indicators

Market Signals
Indicator
CCCC
NPWR
Relative Strength Index (RSI) 53.55 40.77
Support Level $2.14 $1.69
Resistance Level N/A $2.17
Average True Range (ATR) 0.34 0.13
MACD 0.02 0.01
Stochastic Oscillator 38.82 47.67

Price Performance

Historical Comparison
CCCC
NPWR

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.

About NPWR NET Power Inc.

NET Power Inc is a clean energy technology company that has developed a novel power generation system, which it refers to as the NET Power Cycle, designed to produce clean, reliable, and low-cost electricity from natural gas while capturing virtually all atmospheric emissions. The company's business model is to license its technology to customers and enable them to build, own, and operate facilities that utilize the Net Power Cycle. It has conducted a successful demonstration of its technology at the La Porte Demonstration Facility and is developing a utility-scale power plant in Texas named Project Permian.

Share on Social Networks: